MYOMyomo, Inc.

1.730USD-6.99%Mkt Cap: 68.52M $P/E:

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPr…

HeadlineSourceTime
Older
Myomo Q2 Earnings Call Highlights

Myomo (NYSEAMERICAN:MYO) reported second-quarter 2026 revenue growth of 21% as the wearable robotics company continued shifting its patient acquisition strategy toward recurring referral sources and expanded reimbursement relationships. Revenue for the quarter totaled $11.7 million, compared with t

MarketBeat
Myomo Inc (MYO) (Q2 2026) Earnings Call Highlights: Record Orders and Margin Expansion Drive ...

Revenue surges 21% to $11.7 million with gross margin improving to 72.1%, while recurring patient sources double to 53% of total revenue.

GuruFocus.com
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates

Myomo (MYO) delivered earnings and revenue surprises of +30.00% and +14.75%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Simply Wall St.
Zacks
Here Is Why Bargain Hunters Would Love Fast-paced Mover Myomo (MYO)

Myomo (MYO) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Zacks
Myomo, Inc. Q1 2026 Earnings Call Summary

Moby summary of Myomo, Inc.'s Q1 2026 earnings call

Moby
Myomo, Inc. (MYO) Reports Q1 Loss, Beats Revenue Estimates

Myomo (MYO) delivered earnings and revenue surprises of +21.74% and +8.75%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Elevance Expands Myomo Coverage To Support Tech Enabled Care Narrative

Elevance Health (NYSE:ELV) entered into new network participation agreements with Myomo. The agreements expand coverage for advanced orthotic devices to tens of millions of Elevance members. Coverage spans commercial, Medicare Advantage, and Medicaid plans, adding to Elevance's technology-enabled care offerings. For you as an investor, this move speaks directly to how Elevance Health is shaping its core health benefits business around technology-enabled, patient-centered care. The Myomo...

Simply Wall St.
Myomo Inc (MYO) Q4 2025 Earnings Call Highlights: Record Revenue Amid Rising Expenses and ...

Despite achieving its highest revenue quarter, Myomo Inc (MYO) faces increased operating losses and outlines strategic initiatives for future growth.

GuruFocus.com